Tetra Tech Bought Its Way To The Top, Can It Keep Doing This?
Tetra Tech’s resilient revenue base drives double-digit growth. Read why TTEK stock’s strong fundamentals make it a solid ...
5 Stocks & 2 ETFs I'm Buying As The Specter Of Recession Looms
The stock market is in correction territory, with risks from protectionism reminiscent of the 1920s, potentially leading to a ...
Does Regulus Therapeutics Have A Long Cash Runway?
As at December 2024, Regulus Therapeutics had cash of US$76m and no debt. Looking at the last year, the company burnt through US$42m. That means it had a cash runway of around 22 months as of December ...